113. 筋ジストロフィー Muscular dystrophy Clinical trials / Disease details

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03123913 (ClinicalTrials.gov)	December 18, 2017	12/4/2017	Study of Testosterone and rHGH in FSHD	Study of Testosterone and rHGH in FSHD (STARFISH): A Proof-of-Concept Study	Facioscapulohumeral Muscular Dystrophy	Drug: Testosterone Enanthate;Drug: Somatropin	University of Rochester	NULL	Completed	18 Years	65 Years	Male	20	Phase 1	United States
2	EUCTR2015-003195-68-GB (EUCTR)	11/11/2015	26/10/2015	Testosterone therapy in DMD	Observational study of clinical outcomes for testosteronetreatment of pubertal delay in Duchenne Mus ...	Duchenne Muscular Dystrophy MedDRA version: 18.1;Level: PT;Classification code 10013801;Term: Duchen ...	Trade Name: Sustanon 250 Product Name: Sustanon 250 Product Code: PRD2175434 INN or Proposed INN: testost ...	The Newcastle upon Tyne NHS Hospitals Foundation Trust	NULL	Not Recruiting			Female: no Male: yes	20	Phase 3	United Kingdom
3	NCT02571205 (ClinicalTrials.gov)	November 2015	24/8/2015	Testosterone Therapy for Pubertal Delay in Duchenne Muscular Dystrophy	Observational Study of Clinical Outcomes for TestosteroneTreatment of Pubertal Delay in Duchenne Mus ...	Duchenne Muscular Dystrophy	Drug: Sustanon (testosterone)	Newcastle-upon-Tyne Hospitals NHS Trust	NULL	Completed	12 Years	17 Years	Male	15		United Kingdom

First Previous1Next Last